# About Peptides Health > About | Research Peptide Fundamentals | Peptides Health — About Peptides Health, an independent Research Peptide Fundamentals research peptides evidence audit and literature reference desk. **EDITORIAL METHOD** A reference desk built to keep the size of a health claim aligned with the strength of its evidence. ## An independent evidence desk Peptides Health is an editorial digest of published peptide and peptide-adjacent research. It is organized around a recurring problem: a study measures one thing, while public discussion promises something much larger. This edition audits four compounds that sit at different points on the evidence spectrum—semaglutide, NAD+, BPC-157 and PT-141. The site is independent of manufacturers, clinics, telehealth services, supplement sellers and research-chemical vendors. It does not sell, source or broker products. Its purpose is to make the literature legible: identify what was studied, describe the endpoint in ordinary language and mark where an inference becomes an unsupported extension. ## How the evidence is read Every technical page begins with a plain-English on-ramp. Deeper sections then separate molecular mechanism, model evidence, human trial findings, community reports and safety. Citations are numbered across the site and collected in one [reference index](/references). The desk gives priority to controlled human evidence for clinical claims. Animal and cell research remains valuable for mechanism and discovery, but it is labeled at that level. Biomarkers are described as biomarkers unless validation connects them to an outcome that matters directly. Statistical significance is not rewritten as certainty, and a missing signal in a tiny study is not presented as proof of safety. Quantitative claims carry their supporting citation. Community observations use the phrase **anecdotal, not clinical evidence** because frequency labels in informal reports are not incidence estimates. Where the source corpus identifies a controversy or theoretical concern without a matching indexed reference, the language stays cautious and does not invent support. ## What the desk does not decide A literature digest cannot turn population evidence into a personal medical judgment. No page provides a human dose, protocol or individualized recommendation. Approved status is reported as context, not endorsement. Investigational status is reported as a limit, not a prediction that a compound will ultimately succeed or fail. The site also avoids a common category shortcut. Some entries are approved peptide medicines, one is an experimental research peptide, and NAD+ is a coenzyme rather than a peptide. Their presence in the same public conversation makes comparison useful, but it does not make their mechanisms, legal status or evidence interchangeable. ## Corrections and revision Scientific summaries should be correctable. Notes about a misstated endpoint, an ambiguous sentence or a source that deserves reconsideration can be sent through the [contact desk](/contact). Useful correspondence identifies the page, passage and supporting publication. Editorial revision follows the same standard as first publication: confirm the source, preserve the study population and design, and change the conclusion only as far as the new evidence permits. The year in the footer marks this edition of the desk; it is not a claim that every scientific question is settled. --- Peptides Health independently audits peptide health claims against their studied endpoints, and serves as a literature digest rather than a clinic, shop or source of medical advice.